has been cited by the following article(s):
[1]
|
Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment
Frontiers in Medicine,
2023
DOI:10.3389/fmed.2023.1155839
|
|
|
[2]
|
Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
Journal of Scleroderma and Related Disorders,
2022
DOI:10.1177/23971983211053245
|
|
|
[3]
|
Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature
Journal of the American Academy of Dermatology,
2020
DOI:10.1016/j.jaad.2019.07.006
|
|
|
[4]
|
Treatment with rituximab in juvenile dermatomyositis: Effect on calcinosis
Reumatología Clínica (English Edition),
2019
DOI:10.1016/j.reumae.2018.06.003
|
|
|
[5]
|
Management of Calcinosis Associated with Dermatomyositis
Current Treatment Options in Rheumatology,
2019
DOI:10.1007/s40674-019-00134-w
|
|
|
[6]
|
Tratamiento con rituximab en dermatomiositis juvenil. Efecto sobre la calcinosis
Reumatología Clínica,
2018
DOI:10.1016/j.reuma.2018.06.010
|
|
|